This cohort study found that glucagon-like peptide-1 receptor agonist (GLP-1RA) prescriptions were associated with a lower risk of uveitis compared with controls. These findings suggest potential anti ...

How Glucagon-Li ...

Scientists have created a pre-clinical weight loss drug combining GLP-1, GIP, glucagon and peptide YY hormones to match ...

Maintaining weight loss with regular exercise rather than the glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide, ...

Studies states that consuming Palatinose (isomaltulose) improves the body’s hormonal and glycemic response to a second meal ...

The primary analysis included 66,102 participants, and a sub-group analysis focused on 3,313 individuals who were newly ...

Trial participants who received an increased weekly dose of Wegovy lost 19 per cent of their body weight in a year on average ...

Drugs like Ozempic and Mounjaro have made regular headlines in recent years for their ability to facilitate weight loss – ...

BlueGenesLab, a precision genomics company headquartered in Scottsdale, Arizona, today announced the addition of three genes to its clinical testing panel that influence GLP‑1 (glucagon‑like peptide‑1 ...

In this systematic review and meta-analysis of 18 trials, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) significantly ...